The diagnosis of prostate cancer rests in performing a core needle biopsy (CNB) of the prostate in patients with elevated blood prostate-specific antigen (PSA) and/or abnormal digital rectal examination. This evidence concerns the gene KLK3 and prostate carcinoma.